Lin Zhang
- Molecular Biology top 2%
- Plant biochemistry and biosynthesis 14
- Heat shock proteins research 12
- Cancer Research top 2%
- MicroRNA in disease regulation 21
- Cancer-related molecular mechanisms research 13
- Immunology top 5%
- Immunotherapy and Immune Responses 10
- Pharmaceutical Science top 2%
- Biomaterials top 2%
-
- Cancer Immunotherapy and Biomarkers 14
-
- SARS-CoV-2 and COVID-19 Research 13
- COVID-19 Clinical Research Studies 12
- Co-authors
- Francis BurrowsAdeela KamalMarcus F. BoehmJohn SensintaffarLawrence C. FritzPan LiaoGuoyin KaiLuqing Pan
- Partner nations
- ChinaUnited StatesCanada
In The Last Decade
Lin Zhang
239 papers receiving 6.6k citations
Hit Papers
Peers
Comparison fields: 5 of 166
- Molecular Biology 3.9k
- Cancer Research 708
- Immunology 859
- Pharmaceutical Science 222
- Biomaterials 447
Countries citing papers authored by Lin Zhang
This map shows the geographic impact of Lin Zhang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lin Zhang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lin Zhang more than expected).
Fields of papers citing papers by Lin Zhang
This network shows the impact of papers produced by Lin Zhang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lin Zhang. The network helps show where Lin Zhang may publish in the future.
Co-authorship network
The 25 scholars most cited alongside Lin Zhang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 0 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 8 | |
| 4 | 2024 | 4 | |
| 5 | 2024 | 0 | |
| 6 | 2024 | 2 | |
| 7 | 2024 | 7 | |
| 8 | 2023 | 2 | |
| 9 | 2023 | 2 | |
| 10 | 2023 | 7 | |
| 11 | 2023 | 0 | |
| 12 | 2023 | 18 | |
| 13 | 2022 | 20 | |
| 14 | 2021 | 6 | |
| 15 | 2019 | 31 | |
| 16 | Ezrin promotes pancreatic cancer cell proliferation and invasion through activating the Akt/mTOR pathway and inducing YAP translocation | 2019 | 4 |
| 17 | 2016 | 2 | |
| 18 | 2016 | 1 | |
| 19 | CLONING AND PROKARYOTIC EXPRESSION OF A COMPLEMENTARY DNA GENE FOR CYCLOPHILIN FROM CAMELLIA OLEIFERA | 2010 | 1 |
| 20 | Extraction of total RNA and identification of Cod8FAD gene in Camellia oleifera seeds. | 2010 | 0 |
About Lin Zhang
Lin Zhang is a scholar working on Pharmaceutical Science, Biomaterials and Geriatrics and Gerontology, having authored 259 papers that have together received 6.7k indexed citations. Recurring topics across this work include MicroRNA in disease regulation (21 papers), Cancer Immunotherapy and Biomarkers (14 papers), Plant biochemistry and biosynthesis (14 papers), SARS-CoV-2 and COVID-19 Research (13 papers), Cancer-related molecular mechanisms research (13 papers), Heat shock proteins research (12 papers), COVID-19 Clinical Research Studies (12 papers) and Immunotherapy and Immune Responses (10 papers). The work is most often cited by research in Molecular Biology (3.9k citations), Cancer Research (708 citations) and Immunology (859 citations). Lin Zhang has collaborated with scholars based in China, United States and Canada. Frequent co-authors include Francis Burrows, Adeela Kamal, Marcus F. Boehm, John Sensintaffar, Lawrence C. Fritz, Pan Liao, Guoyin Kai, Luqing Pan, Jianbo Xiao and Hui Xu. Their work appears in journals such as Nature, Journal of Biological Chemistry and Circulation.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.